State Street Corp Applied Molecular Transport Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $1.11 Million - $3.07 Million	-401,216 Reduced 87.93%	55,055 $160,000
Q1 2022 May 16, 2022	BUY	$5.63 - $13.88 $160,072 - $394,636	28,432 Added 6.65%	456,271 $3.43 Million
Q4 2021 Feb 14, 2022	SELL	$13.23 - $26.05 $10.9 Million - $21.5 Million	-824,312 Reduced 65.83%	427,839 $5.98 Million
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $1.09 Million - $1.97 Million	42,290 Added 3.5%	1,252,151 $32.4 Million
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $26.7 Million - $43.1 Million	670,921 Added 124.49%	1,209,861 $55.3 Million
Q1 2021 May 17, 2021	BUY	$30.5 - $74.14 $53,253 - $129,448	1,746 Added 0.33%	538,940 $23.7 Million
Q4 2020 Feb 16, 2021	BUY	$29.39 - $35.0 $11.1 Million - $13.2 Million	377,725 Added 236.86%	537,194 $16.5 Million
Q3 2020 Nov 10, 2020	BUY	$20.49 - $33.58 $3.27 Million - $5.35 Million	159,469 New	159,469 $5.07 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.